 |
Propanolamines - Blood
Research News and Information
Definition of 'Propanolamines'AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Common names: Propanolamines; Aminopropanols |
Monday, November 23, 2009
30 Aug 2009 
1. The objective of this study was to investigate the effect of concomitantly administered silymarin on the pharmacokinetics of talinolol, a typical substrate for P-glycoprotein (P-gp), in healthy Chinese volunteers and its association with a ... Read more...
27 Feb 2009 The authors investigated the effect of herbal medicine Schisandra chinensis extract (SchE) and Ginkgo biloba extract (GBE) on the oral pharmacokinetics of P-glycoprotein substrate talinolol in humans. Twelve healthy male volunteers took a single ... Read more...
Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
29 Nov 2008 OBJECTIVE: To compare the pharmacokinetic properties and bioavailability following oral and IV administration of bisoprolol, a second-generation beta1-adrenoceptor-selective blocking agent, with those of carvedilol, a third-generation beta1/beta2 ... Read more...
Latest indexed articles for 'Propanolamines - Blood'
These are the very latest articles for this heading:
- Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers. 30 Aug 2009
- Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. 27 Feb 2009
- Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs. 29 Nov 2008
- Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). 10 Nov 2008
- Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol. 30 Oct 2008
- Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists. 23 Sep 2008
- Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS. 9 Sep 2008
- Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. 29 Jun 2008
- Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans. 17 Jun 2008
- Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. 20 May 2008
- Simultaneous enantioseparation and sensitivity enhancement of basic drugs using large-volume sample stacking. 29 Sep 2007
- Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
10 Sep 2007 - Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study. 20 Jul 2007
- Determination of bevantolol in human plasma by high performance liquid chromatography using solid phase extraction technique. 29 Jun 2007
- Application of liquid chromatography-tandem mass spectrometry method for the analysis of new nonselective beta-adrenergic blocker 1-(1-H-indol-4-yloxy)-3-{[2-(2-methoxy phenoxy)ethylo]amino}propan-2-ol (2F109) in rat plasma. 29 Jun 2007
- Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography. 29 Jun 2007
- Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate. 13 Jun 2007
- Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. 26 Apr 2007
- Determination of talinolol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry: application to pharmacokinetic study. 3 Apr 2007
- Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysis. 27 Feb 2007
See a longer list of these articles.
Technical information about 'Propanolamines'
Definition: AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.
Registry Number: 0
Descriptor UI: D011412
Alternative terms: Propanolamines; Aminopropanols;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D02.033.100.624; D02.033.755.624; D02.092.063.624;
History Note: 74